MedTrace Logo

Condition of Submental Fullness and Treatment Outcomes Registry

NCT02438813 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1029

Last updated 2018-10-05

Study results available
· View outcomes & findings →

Summary

The primary objective of this registry is to develop a comprehensive understanding of the condition of submental (SM) fullness due to submental fat (SMF), how it is treated in current clinical practice, and the risks and benefits associated with its treatment.

Conditions

  • Submental Fullness

Interventions

DRUG

Deoxycholic acid

Deoxycholic acid (ATX-101) injection as the treatment of SMF as per standard of care in clinical practice.

PROCEDURE

Surgical Procedures

Surgical procedures for treatment of SMF as per standard of care in clinical practice.

PROCEDURE

Laser Liposuction

Laser Liposuction for the treatment of SMF as per standard of care in clinical practice..

DEVICE

Energy Devices

Energy Devices for the treatment of SMF as per standard of care in clinical practice.

OTHER

Other Treatments

Other treatments for SMF as per standard of care in clinical practice.

Sponsors & Collaborators

  • Kythera Biopharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Rina Patel, MS, CCRA · Allergan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-11
Primary Completion
2016-11-10
Completion
2016-11-10

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438813 on ClinicalTrials.gov